Targeting the microRNAs in exosome: A potential therapeutic strategy for alleviation of diabetes-related cardiovascular complication
Authors:
- 1 November 2021
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 173, 105868
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81670424, 81900424)
- Natural Science Foundation of Hunan Province (2019JJ40258, 2019JJ50502)
This publication has 96 references indexed in Scilit:
- Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarksNature Immunology, 2012
- Microparticles: targets and tools in cardiovascular diseaseTrends in Pharmacological Sciences, 2011
- Microglia/Macrophages Migrate through Retinal Epithelium Barrier by a Transcellular Route in Diabetic RetinopathyThe American Journal of Pathology, 2011
- MicroRNAs as new maestro conducting the expanding symphony orchestra of regenerative and reparative medicinePhysiological Genomics, 2011
- Mammalian microRNAs predominantly act to decrease target mRNA levelsNature, 2010
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- MicroRNA‐320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN‐LIKE GROWTH FACTOR‐1 IN TYPE 2 DIABETIC RATSClinical and Experimental Pharmacology and Physiology, 2009
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- A pancreatic islet-specific microRNA regulates insulin secretionNature, 2004
- Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)Kidney International, 2003